Showing results (81-90 of 281) with videos related to
Sort By:
Pageof 29
Cancer Research|April 1, 1994
Molecular biomarkers for aflatoxins and their application to human cancer preventionJ D Groopman, G N Wogan, B D Roebuck, et al.Carcinogenesis|January 1, 1982
Formation of an activated N-nitroso compound in nitrite-treated fava beans (Vicia faba)B G Piacek-Llanes, S R TannenbaumFree Radical Biology & Medicine|January 1, 1996
NO-induced oxidative stress and glutathione metabolism in rodent and human cellsS Luperchio, S Tamir, S R TannenbaumCarcinogenesis|June 1, 1993
Quantitative analysis of aflatoxin-albumin adductsF Z Sheabar, J D Groopman, G S Qian, et al.Cancer Research|August 14, 1999
Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cellsJ K Jeong, G N Wogan, S S Lau, et al.Biochimica Et Biophysica Acta|June 23, 1976
Aflatoxin inhibition of glucocorticoid finding capacity of rat liver nucleiT W Kensler, W F Busby, N E Davidson, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1978
Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liverR G Croy, J M Essigmann, V N Reinhold, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumorsG McMahon, E F Davis, L J Huber, et al.Carcinogenesis|May 23, 2002
Excretion of the N(2)-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humansW G Stillwell, R Sinha, S R TannenbaumCarcinogenesis|June 1, 1986
In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adductJ R Babson, S E Russo-Rodriguez, W H Rastetter, et al.Pageof 29